Sign in

Tyra Biosciences, Inc.

Income Statement - Tyra Biosciences, Inc. (TYRA)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.13 0.10 0.08 0.06 0.03 0.01 0.00
Operating income -0.13 -0.10 -0.08 -0.06 -0.03 -0.01 0.00
Non-operating income (net) 0.01 0.02 0.01 0.00 0.00 0.00 0.00
Income before tax -0.12 -0.09 -0.07 -0.06 -0.03 -0.01 0.00
Income tax expense 0.00 0.00 0.00 0.00
Net income -0.12 -0.09 -0.07 -0.05 -0.03 -0.01 0.00
Show Quarterly Income Statement

Income Statement - Tyra Biosciences, Inc. (TYRA)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.03 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Operating income -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.03 -0.02 -0.02 -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00
Income tax expense 0.00 0.01 0.00 0.00 0.00 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00
4 days ago

Balance Sheet - Tyra Biosciences, Inc. (TYRA)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.26 0.34 0.20 0.25 0.30 0.02 0.00
Accounts receivable, net 0.00 0.00
Other current assets 0.01 0.00 0.01 0.01 0.00 0.00 0.00
Total current assets 0.27 0.35 0.21 0.26 0.30 0.02 0.00
Total non-current assets + 0.02 0.02 0.01 0.01 0.00 0.00 0.00
Total assets 0.28 0.36 0.23 0.27 0.31 0.02 0.00
Total current liabilities + 0.02 0.01 0.02 0.01 0.00 0.00 0.01
Total non-current liabilities + 0.01 0.01 0.01 0.00 0.00 0.03 0.00
Total liabilities 0.02 0.02 0.02 0.01 0.00 0.03 0.01
Total stockholders' equity + 0.26 0.34 0.20 0.26 0.30 -0.01 0.00
Common shares outstanding 60 57 43 42 41 43 43
Show Quarterly Balance Sheet

Balance Sheet - Tyra Biosciences, Inc. (TYRA)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 0.38 0.26 0.27 0.30 0.32 0.34 0.36 0.37 0.38 0.20 0.22 0.23 0.24 0.25 0.26 0.28 0.29 0.30 0.31 0.14 0.14 0.02 0.00 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.39 0.27 0.28 0.30 0.32 0.35 0.37 0.38 0.39 0.21 0.22 0.24 0.25 0.26 0.27 0.28 0.29 0.30 0.31 0.14 0.14 0.02 0.02
Total non-current assets + 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.41 0.28 0.30 0.32 0.34 0.36 0.38 0.39 0.40 0.23 0.24 0.25 0.26 0.27 0.28 0.29 0.30 0.31 0.32 0.14 0.14 0.02
Total current liabilities + 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 0.16 0.03
Total liabilities 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.16 0.16 0.03
Total stockholders' equity + 0.39 0.26 0.28 0.30 0.32 0.34 0.36 0.38 0.39 0.20 0.22 0.24 0.25 0.26 0.27 0.28 0.29 0.30 0.31 -0.02 -0.02 -0.01
Common shares outstanding 62 60 60 60 59 59 59 59 52 43 43 43 42 42 42 42 42 41 9 37 22 22 22 1 1
4 days ago

Cash Flow - Tyra Biosciences, Inc. (TYRA)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + -0.10 -0.07 -0.05 -0.05 -0.02 -0.01 0.00
Cash flow from investing + 0.07 -0.10 -0.14 0.00 0.00 0.00 0.00
Cash flow from financing + 0.01 0.20 0.00 0.00 0.31 0.02 0.00
Change in cash -0.01 0.03 -0.19 -0.05 0.29 0.02 0.00
Show Quarterly Cash Flow

Cash Flow - Tyra Biosciences, Inc. (TYRA)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.03 -0.02 -0.02 -0.02 -0.03 -0.02 -0.02 -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from investing + -0.12 0.03 -0.01 0.02 0.03 0.01 0.02 -0.14 0.02 -0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.18 0.00 0.13 0.00 0.00 0.00 0.02
Change in cash 0.01 0.02 -0.04 0.00 0.01 -0.01 0.00 -0.15 0.20 -0.16 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 0.18 -0.01 0.13 0.00 0.00 0.00 0.02
4 days ago

Tyra Biosciences, Inc. (TYRA) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Net Income

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Operating Cashflow

1Y 2Y 5Y Max
9 days ago

Tyra Biosciences, Inc. (TYRA) - Other Non Operating Income

1Y 2Y 5Y Max
9 days ago